This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Yuhan Corporation. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Hyok Jun Cho: Innovator in Pharmaceutical Compositions
Introduction
Hyok Jun Cho is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit therapeutic potential.
Latest Patents
Hyok Jun Cho holds 3 patents that focus on innovative pharmaceutical compositions. His latest patents include the development of triazolones, tetrazolones, and imidazolones, or their salts, which are designed to treat nonalcoholic hepatosteatosis (NASH). These compounds demonstrate inhibitory activity on VAP-1, making them valuable in medical applications. Another significant patent involves 3,3-difluoroallylamines or their salts, which also exhibit potent inhibitory activity on VAP-1 and are aimed at the same medical condition.
Career Highlights
Hyok Jun Cho is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has been instrumental in advancing the company's research and development efforts in innovative drug formulations.
Collaborations
He has collaborated with notable coworkers, including Hee Jae Tak and Eun Kyung Kim, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Hyok Jun Cho's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to pave the way for new treatments that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile